Magnetar Financial LLC Ptc Therapeutics, Inc. Transaction History

Magnetar Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $442,931 - $782,569	-17,302 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $576,675 - $771,669	17,302 New	17,302 $646,000
Q3 2021 Nov 12, 2021	SELL	$37.01 - $44.74 $905,079 - $1.09 Million	-24,455 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$37.95 - $49.37 $928,067 - $1.21 Million	24,455 New	24,455 $1.03 Million
Q4 2020 Feb 12, 2021	SELL	$47.96 - $67.64 $492,453 - $694,527	-10,268 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$45.41 - $57.07 $466,269 - $585,994	10,268 New	10,268 $480,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.